Literature DB >> 17129701

Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.

T W Chen1, C M Chu, J C Yu, C J Chen, D C Chan, Y C Liu, C B Hsieh.   

Abstract

AIM: To compare the utility of seven commonly used staging systems in the prediction of survival among patients with hepatocellular carcinoma (HCC) undergoing major or minor hepatectomy.
METHODS: All patients were classified by the Okuda, the TNM, the CLIP, the BCLC, the CUPI, the JIS and the MELD classifications to estimate the probabilities of survival. Survival curves were calculated using the Kaplan-Meier method and were examined using log-rank testing. The overall predictive power for patient survival with each staging system was evaluated using linear trend chi(2) tests and from the area under the receiver operating characteristic (ROC) curve.
RESULTS: In our patient cohort, the log-rank test and the linear trend chi(2) test of the CLIP and JIS systems gave better results than did the other staging systems. The discriminatory ability of the CLIP and JIS staging for death, evaluated by ROC curve areas, was also better. In the subgroups of major hepatectomy patients with a non-cirrhotic liver or minor hepatectomy patients with a cirrhotic liver, the CLIP and JIS systems showed similar better performances in these three tests. The discriminatory ability of the CLIP system was the best in major hepatectomy patients with a non-cirrhotic liver while JIS score discriminated best in minor hepatectomy patients with a cirrhotic liver.
CONCLUSION: Among the seven staging systems, the CLIP and JIS systems perform better than do the others. While the CLIP system should be considered to stage major hepatectomy patients, the JIS system could be chosen to stage minor hepatectomy patients.

Entities:  

Mesh:

Year:  2006        PMID: 17129701     DOI: 10.1016/j.ejso.2006.10.012

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  18 in total

1.  Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery.

Authors:  Lei-Bo Xu; Jie Wang; Chao Liu; Hao-Wei Pang; Ya-Jin Chen; Qing-Jia Ou; Ji-Sheng Chen
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Li Zhou; Jing-An Rui; Da-Xiong Ye; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 3.  Staging systems of hepatocellular carcinoma: a review of literature.

Authors:  Marcello Maida; Emanuele Orlando; Calogero Cammà; Giuseppe Cabibbo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 4.  Staging systems for hepatocellular carcinoma: Current status and future perspectives.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Hisao Tajiri
Journal:  World J Hepatol       Date:  2015-03-27

5.  Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.

Authors:  Jean-Nicolas Vauthey; Elijah Dixon; Eddie K Abdalla; W Scott Helton; Timothy M Pawlik; Bachir Taouli; Antoine Brouquet; Reid B Adams
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 6.  Treatment of hepatocellular carcinoma: a systematic review.

Authors:  Shibo Lin; Katrin Hoffmann; Peter Schemmer
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

7.  A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Li-Qun Yang; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-06       Impact factor: 4.553

8.  Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.

Authors:  Asmaa I Gomaa; Alzhraa Al-Khatib; Wael Abdel-Razek; Mohammed Saad Hashim; Imam Waked
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

9.  Comparative performances of staging systems for early hepatocellular carcinoma.

Authors:  Hari Nathan; Gilles Mentha; Hugo P Marques; Lorenzo Capussotti; Pietro Majno; Luca Aldrighetti; Carlo Pulitano; Laura Rubbia-Brandt; Nadia Russolillo; Benjamin Philosophe; Eduardo Barroso; Alessandro Ferrero; Richard D Schulick; Michael A Choti; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

10.  Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.

Authors:  Kai-Zhong Luo; Toshiyuki Itamoto; Hironobu Amano; Akihiko Oshita; Yuichiro Ushitora; Yoshisato Tanimoto; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.